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ABSTRACT 
INTRODUCTION:  Orthostatic hypotension is a serious risk for crewmembers 
returning from spaceflight.  Numerous cardiovascular mechanisms have been 
proposed to account for this problem, including vascular and cardiac dysfunction, 
which we studied during bed rest.  METHODS:  Thirteen subjects were studied 
before and during bed rest.  Statistical analysis was limited to the first 49-60 days 
of bed rest, and compared to pre-bed rest data.  Ultrasound data were collected 
on vascular and cardiac structure and function.  Tilt testing was conducted for 30 
minutes or until presyncopal symptoms intervened.  RESULTS:  Plasma volume 
was significantly reduced by day 7 of bed rest.  Flow-mediated dilation in the leg 
was significantly increased at bed rest day 49.  Arterial responses to nitroglycerin 
differed in the arm and leg, but did not change as a result of bed rest.  Intimal-
medial thickness markedly decreased at bed rest days 21, 35 and 49.  Several 
cardiac functional parameters including isovolumic relaxation time, ejection time 
and myocardial performance index were significantly increased (indicating a 
decrease in cardiac function) during bed rest.  There was a trend for decreased 
orthostatic tolerance following 60 days of bed rest.  DISCUSSION:  These data 
suggest that 6º head-down tilt bed rest alters cardiovascular structure and 
function in a pattern similar to short duration spaceflight.  Additionally, the 
vascular alterations are primarily seen in the lower body, while vessels of the 
upper body are unaffected.  
KEY WORDS: spaceflight, orthostatic intolerance, hypotension, fluid-shift, 
plasma volume
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INTRODUCTION 
Spaceflight provokes numerous untoward effects on the cardiovascular system.  
These effects have been shown in spaceflight studies (1), bed rest analog 
studies (20) and animal studies (18).  Post-spaceflight orthostatic hypotension 
has been the subject of intense study during the last 20 years, both during 
spaceflight and head-down tilt bed rest investigations.  This problem appears to 
develop from a series of in-flight cardiovascular changes including a relative 
hypovolemia, initiated by the cephalad fluid shift and a lack of arterial 
baroreceptor input (2,3,10,16).  Other cardiovascular alterations have also been 
reported, including decreased cardiac function (21,25), decreased aerobic 
capacity (13), changes in vascular structure and function (10,29) and possible 
cardiac rhythm abnormalities (6,9).   
 
Head-down tilt bed rest has become a primary research tool to examine 
mechanisms and test countermeasures for cardiovascular alterations.  There is 
abundant literature supporting the utility of bed rest as an analog for multiple 
organ systems.  One of the drawbacks of bed rest literature is the lack of 
standardization.  This study is part of a NASA Flight Analogs Project initiative to 
conduct multisystem research on bed rest subjects under strictly standardized 
conditions. 
 
We tested the hypothesis that arterial flow-mediated dilation responses, dilation 
in response to nitroglycerin and arterial structure would all change during bed 
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rest.  Additionally, we tested the hypothesis that arteries in the arm would follow 
different patterns of change than arteries in the leg during head-down tilt bed 
rest.  No bed rest study to date has addressed this possibility.  Finally, we tested 
the hypothesis that orthostatic tolerance would decrease following bed rest. 
 
Spaceflight and bed rest may also induce changes in cardiac function.  Recent 
work has shown a decrease in ventricular mass (21,24) and stroke volume 
(5,15,21); however, more comprehensive measures of cardiac function are 
lacking.  In addition to the above standard measures, we studied the effects of 
bed rest on numerous other indicators of cardiac function such as isovolumic 
relaxation time and myocardial performance index.  We tested the hypothesis 
that cardiac function, as measured by echocardiography, would be decreased by 
exposure to bed rest. 
 
METHODS 
General 
Refer to Meck, et al. (17) for description of the protocol, general conditions of the 
study and the use of long duration head-down tilt bed rest as a model for 
spaceflight.  Bed rest and test protocols were reviewed and approved by the 
Johnson Space Center Committee for the Protection of Human Subjects, the 
University of Texas Medical Branch (UTMB) Institutional Review Board and the 
UTMB General Clinical Research Center Science Advisory Committee.  Subjects 
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received verbal and written explanations of the bed rest and test protocols prior 
to providing written informed consent. 
 
Subjects 
Data from 13 subjects are included in this study (eight men and five women).  
Three subjects experienced 60 days of head-down tilt bed rest, six subjects 
experienced 90 days of head-down tilt bed rest and four subjects experienced 
44-53 days of head-down tilt bed rest (truncated due to Hurricane Rita, no post-
bed rest data were acquired on these subjects).  Testing on females was timed to 
always occur during the first six days of the menstrual cycle in order to minimize 
the effects of estrogen and progesterone on the cardiovascular system. 
 
Plasma Volume 
Plasma volume was measured by the carbon monoxide rebreathing (CORB) 
technique as previously reported (14,26).  In this study, plasma volume was 
corrected (plasma volume index, PVI) by body surface area (BSA). 
( ) ( )725.0425.02 )()(007184.0)( cmHeightkgWeightmBSA ××=  
 
Flow-Mediated Dilation 
Subjects were placed in the supine position and instrumented with a three-lead 
ECG.  A Dinamap automatic blood pressure cuff (Johnson & Johnson, Arlington, 
TX) was placed on the non-imaged arm to obtain a baseline blood pressure.  An 
occlusive pressure cuff (D. E. Hokanson, Inc., Bellevue, WA) was applied to the 
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limb used for imaging.  Imaging of the brachial artery was performed by a 
registered sonographer using a Philips HDI 5000 (Bothel, WA) with a 12 MHz 
transducer above the antecubital fossa.  When the optimal imaging site was 
acquired, the site was marked with a permanent marker and the same position 
was used throughout the study.  In addition, ultrasound images from the initial 
procedure were printed and reviewed prior to subsequent imaging sessions.  
When possible, arterial branches were included as landmarks.  Furthermore, a 
photograph was taken during the procedure to show the position of the 
transducer on the skin.  This photograph was used to ensure proper placement 
of the ultrasound probe for subsequent tests. 
 
Resting diameter images of the brachial artery in the arm were optimized to allow 
clear visualization of the intimal-medial borders.  The images were then enlarged 
to improve the accuracy of subsequent measurements.  Three images at end-
diastole and three at peak systole were stored digitally for off-line analyses.  
Blood flow parameters including peak systolic velocity, pulsatility index and 
velocity time interval were also evaluated and stored.  After acquisition of 
baseline images, an occlusive cuff (Hokanson) was inflated to 50 mmHg above 
the resting systolic pressure and cessation of flow was verified by Doppler 
ultrasound.  The cuff remained inflated for five minutes, at which point the cuff 
was rapidly deflated.  Pulsed Doppler of the flow response was stored at 10 and 
20 seconds post-deflation.  Images of the brachial artery were stored every 15 
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seconds, starting at 30 seconds post-deflation and continued until the third 
minute.  Additional images were acquired at minutes four and five. 
 
Flow-mediated dilation of the anterior tibial artery in the leg was accomplished 
following a similar protocol. The anterior tibial artery was chosen because it is of 
similar size to the brachial artery and is superficial enough to obtain high quality 
ultrasound images.  The occlusive cuff was placed just proximal to the knee and 
was inflated to 70 mmHg over resting systolic blood pressure.  This pressure was 
maintained for seven minutes on the leg prior to deflation.  The remainder of the 
procedure was identical to that used for the brachial artery, described above.  
Preliminary results in our lab have shown that this protocol achieved a similar 
hyperemic response to that seen in the arm at 50 mmHg supra-systolic pressure 
for five minutes (data not shown). 
 
Measurement and analysis of data were performed off-line on a desktop 
computer using ProSolv Cardiovascular Analyzer 3.0.50 (Indianapolis, IN).  .  
Measurements were made during diastole for consistency.  Each image was 
measured by two experienced sonographers in a double-blind fashion.  If a 
significant (greater than 10%) discrepancy between the two analyses was found, 
a third sonographer repeated the measurement.  Doppler measurements and 
calculations were performed by an automated analysis feature of the ultrasound 
system. 
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For intimal-medial thickness measurements, three diastolic brachial artery 
images were stored at the R wave and three systolic images were stored at the 
end of the T wave from a superimposed ECG.  The still frame images were 
stored in DICOM format and analyzed off line on Prosolv Cardiovascular 
Analyzer 3.0.50 (Indianapolis, IN).  The posterior segment of the artery was 
enhanced with a Region Of Interest (ROI) magnification tool.  Intimal-medial 
thickness measurements were made by two independent and blinded 
sonographers from three sequential images taken at the R wave.  The 
measurements were made, with a caliper tool, from the central region of each 
image.  The anterior interface of the intima was selected as the first linear 
interface echo; the second caliper was set at the medial adventitia line, defined 
as the next linear interface followed by a dark separating line. 
 
Direct Arterial Dilation 
Imaging of the brachial and anterior tibial arteries after administration of 
nitroglycerin (0.4 mg sublingual) was performed on the same day as, but no 
sooner than one hour after the completion of, the flow-mediated dilation 
procedure.  The same imaging techniques and imaging locations were used as 
previously described. 
 
Three baseline images were acquired and digitally stored at end-diastole prior to 
administration of sublingual nitroglycerin.  The artery was imaged continuously 
throughout the session to assure the same position was maintained.  Starting at 
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three minutes after the nitroglycerin administration, three images per minute were 
stored digitally for off-line analysis.  One image per minute was measured live to 
monitor the time course of dilation.  Imaging was continued until two minutes 
following the peak dilator response.  The images were analyzed off-line by 
experienced sonographers who were blinded to the subject information.   Any 
discrepancies greater than 10% were re-evaluated by a third sonographer. 
 
Cardiac Function 
Subjects were placed in the left lateral decubitus position.  During head-down tilt 
bed rest, the subjects maintained the 6° head-down tilt.  American Society of 
Echocardiography standards were used in acquiring images (HDI 5000, Philips 
Medical, Bothel, WA).  M-mode echocardiography was used to measure 
interventricular septal thickness (IVST), posterior wall thickness (PWT) and left 
ventricular diameter in systole (LVEDS) and diastole (LVEDD).  From these 
measurements, calculations of systolic function were made, including ejection 
fraction, stroke volume, velocity of circumferential shortening and left ventricular 
mass.  Left ventricular mass was calculated as follows: LVM (g) = 0.8{1.05 
[(LVEDD + IVST + PWT)3 - (LVEDD)3] + 0.6}.  Myocardial performance index 
(MPI), a global measure of both systolic and diastolic function, was calculated as 
the ratio of left ventricular isovolumic contraction time plus isovolumic relaxation 
time divided by ejection time.  Assessment of all the valves was accomplished 
using pulsed, continuous and color Doppler.  Images were stored digitally and on 
videotape for subsequent off-line analysis.  The echocardiography protocol 
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utilized views consistent with standards established by the American Society of 
Echocardiography (ASE). 
 
Tilt Test 
Subjects were placed on a tilt table and a Dinamap blood pressure cuff was 
placed on the upper arm.  A Finapres (Ohmeda Medical, Netherlands) finger 
blood pressure cuff was placed on a finger of the opposite hand for continuous 
blood pressure measurement.  Continuous measures of heart rate, ECG, arterial 
pressure and aortic blood flow [systolic velocity integral obtained by Doppler 
ultrasound (2 MHz probe) of the proximal ascending aorta] were recorded for five 
minutes while supine (pre-bed rest) or at 6° head-down tilt (BR44-BR60), and 
during tilt.  This technique has been validated by previous studies (19,23).  Beat 
to beat stroke volume (systolic velocity integral X cross-sectional area) 
determined by two-dimensional ultrasound (2–4 MHz phased array probe) at 
cusp insertion, cardiac output (stroke volume X heart rate) and total peripheral 
resistance (mean arterial pressure/cardiac output) were all calculated off-line.  
The subjects were then tilted upright to 80º for 30 minutes or until symptoms of 
presyncope intervened. 
 
Data and Statistical Analysis 
All vascular measurements and plasma volumes were taken as close as possible 
to BR-5 (baseline) and at days BR7, BR21, BR35, BR49, BR60, BR90 and at 
BR+3  post-bed rest.  Statistical analysis was only performed for the first 60 days 
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of the study due to the low number of subjects that completed the entire 90 day 
protocol. 
 
Data are presented as mean ± standard error unless otherwise noted.  Statistics 
were performed on a desktop computer using SigmaStat® commercial software 
v. 3.1 (Richmond, CA).  All data were tested for normality (Kolmogorov-Smirnov 
test) and equal variance (Levene Median test).  Plasma volume, cardiac 
parameters and vital statistics were analyzed using a 1-way Repeated Measures 
ANOVA with a Bonferroni corrected pairwise comparison.  Intimal-medial 
thickness was compared with a 2-way ANOVA with a Bonferroni correction for 
pairwise comparisons.  Flow-mediated dilation and nitroglycerin data failed the 
normality test and were compared using Friedman’s Repeated Measures 
ANOVA on ranks.  Pairwise comparisons were made using Tukey’s test.   Tilt 
data were analyzed with a Kaplan-Meier survival analysis comparing pre-bed rest 
data with data from BR44-BR60.  Significance for all tests was accepted at P ≤ 
0.05. 
 
RESULTS 
Vital statistics and baseline hemodynamic measurements are shown in Table I.  
No differences were found during bed rest for systolic or diastolic blood pressure, 
heart rate, weight or body mass index. 
 
Plasma Volumes 
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Plasma volumes index (PVI, plasma volume / body surface area), is shown in 
Figure 1 for baseline through 90 days of bed rest.  Baseline PVI was 1.49 ± 
0.126 L/m2.  By day BR7, PVI fell significantly by 15%, to 1.26 ± 0.166 L/m2 (P < 
0.001).  By day BR49 of bed rest, PVI was 1.22 ± 0.095 L/m2 (P < 0.001), a total 
decrease of 18%.  There were no differences between days BR7, BR21, BR35 or 
BR49 of bed rest (P = NS). 
 
Arterial Function 
Flow-Mediated Dilation 
Flow-mediated arterial dilations (Figure 2) are expressed, on the y-axis, as the 
difference between the percent dilation on the bed rest day minus the percent 
dilation during the pre-bed rest baseline (delta).  The responses of the brachial 
artery did not change (P = NS); however, dilation was significantly increased in 
the anterior tibial artery by BR49 (day effect, P = 0.001). 
 
Direct Arterial Dilation 
There were no differences between bed rest days for dilations induced by the 
nitric oxide (NO) donor nitroglycerin (Figure 3, P = NS in the brachial or the 
anterior tibial artery).  However, there was a significant difference in the dilator 
response between the brachial artery and anterior tibial artery (treatment effect, 
P < 0.001). 
 
Intimal-Medial Thickness 
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The thickness of the arterial wall, shown in Figure 4, decreased significantly 
during bed rest for the anterior tibial artery (P < 0.001), but not in the brachial 
artery, when compared to the baseline value.  This effect was seen at days 
BR21, BR35 and BR49.  There was also a significant difference between the 
brachial and anterior tibial artery (treatment effect, P = 0.001). 
 
Cardiac Function 
Measures of cardiac function are shown in Table II.  Significant decreases during 
bed rest were seen in left ventricular systolic diameter (BR7, P = 0.035; BR49, P 
= 0.005), left ventricular diastolic diameter (P = 0.015 at BR21), IVRT (P < 0.025 
for days BR7, BR21, BR31 and BR49) and ejection time (P < 0.03 on days BR21, 
BR31 and BR49).  Myocardial performance index increased, which indicates a 
decrease in performance, and became statistically significant by day BR7 (P < 
0.033) and was also significantly higher at days BR31 and BR49 (P < 0.005). 
 
Tilt Test 
The ability of test subjects to tolerate 80° upright tilt was analyzed with a Kaplan-
Meier survival analysis (Figure 5).  There was a trend (P = 0.1) for survival to be 
lower following 60 days of bed rest when compared to pre-bed rest results. 
 
DISCUSSION  
Resources on the remaining Space Shuttle flights and the International Space 
Station are extremely limited.  It is clear that ground based analogs to spaceflight 
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will be critical to expand our understanding of the causes of spaceflight induced 
decrements in cardiovascular function.  Head-down tilt bed rest has been used 
as a model for spaceflight, however the lack of standardization and varying 
durations of bed rest complicate interpretation.  Our data show that 
cardiovascular alterations during longer term, head-down tilt bed rest are similar 
to those seen in spaceflight 
Plasma Volume 
The time course and magnitude of plasma volume loss is critical to the 
understanding of the mechanisms linking bed rest and spaceflight.  While plasma 
volume is not the separating factor in determining presyncope in crewmembers 
(16,27), it is believed to be the triggering mechanism that leads to subsequent 
dysfunction.  Previous bed rest reports detail plasma volume losses ranging from 
4% to 17%, depending on the protocol (26), which is similar to the data 
presented here.  Our data are also similar to those reported from spaceflight 
(16,26) which show plasma volume losses ranging from 7% to 19.5%.  These 
new data show that the entire plasma volume loss occurs within the first seven 
days (our earliest time point), and is maintained in a steady state throughout the 
49 days of bed rest (Figure 1).  The fluid balance data shown in the overview 
section of this issue (17) shows an early, marked diuresis which confirms the 
plasma volume data.  These results are consistent with spaceflight data as well.  
It has been shown that plasma volume is reduced by 16% by day 2 of spaceflight 
and 11% at day 7-8 of spaceflight (12).  In these bed rest subjects, there was a 
trend for decreased orthostatic tolerance and three of these ten (30%) were 
 15  
unable to complete ten minutes of tilt (Figure 5).  This is nearly identical to the 
percentage of crewmembers unable to complete ten minutes of tilt following short 
duration spaceflight (27).  Taken together, these data show that bed rest is a 
good model for spaceflight-induced plasma volume losses in both magnitude and 
time course. 
 
Arterial Function 
This study used a new approach to study arteries by measuring both structure 
and function.  In addition, we compared and contrasted responses from an artery 
in the arm (brachial) and a similar sized artery in the leg (anterior tibial) during 
bed rest.  This approach has added important new information.  In the brachial 
artery, none of the measured responses changed over the course of bed rest.  
Conversely, in the anterior tibial artery there were two important changes.  First, 
the intimal-medial thickness was profoundly reduced.  This confirms findings in 
animal studies and suggests that the vascular smooth muscle itself remodels in 
response to disuse during bed rest.  Prior work from this laboratory suggests that 
the fluid shifts and relative hypovolemia, precipitated by both bed rest and 
spaceflight, may cause a loss of interstitial fluid volume (24), which could cause a 
change in function independent of contractile dysfunction.  In cardiac tissue, 
dehydration causes diastolic dysfunction due to ventricular stiffening (25).  In 
smooth muscle it could also increase stiffness.  In addition, dehydration could 
reduce the diffusion distance from the endothelial layer, so that a greater 
concentration of NO reaches the smooth muscle.   
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 Not all vascular beds respond to simulated microgravity in a parallel fashion.  
There are recent reports from several groups detailing structural remodeling of 
resistance vasculature in rats after hind limb suspension (8,22,29).  In this model, 
the rat is suspended by the tail to achieve fluid shifts similar to those in 
microgravity.  As a result, the forelimbs are utilized for locomotion more than 
during control, and the hind limbs are utilized less.  This causes changes in the 
two primary mechanical forces that act on the vasculature: transmural pressures 
and shear stress.  During suspension, these forces increase in the forelimbs, but 
decrease in the hind limbs.  Both the smooth muscle and the endothelium 
respond to these changes.  Vasculature in the forelimbs show hypertrophic 
remodeling while that in the hind limbs show atrophic remodeling (28).  Following 
hind limb suspension, vasodilatory responses to acetylcholine injections (an 
endothelium-dependent response) are reduced in the femoral artery and soleus 
arterioles (22), both of which have been exposed to reduced blood flow and 
shear stress, but increased in the carotid artery, which has been exposed to 
increased blood flow and shear stress (11).  The media cross-sectional area in 
arteries also decreases in the hind limb (8,22), but not the forelimb, suggesting 
atrophic remodeling in the hind limb (8).  The hind limb vessels also have a 
diminished responsiveness to vasoconstrictors (7). 
 
The second change in anterior tibial artery function over the course of bed rest 
was an increase in flow-mediated dilation. This could be related to the change in 
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wall thickness discussed above, as a thinner arterial wall may allow a greater 
concentration of NO to reach the smooth muscle cells.  The third response, 
dilation in response to sublingual nitroglycerin, was unchanged.  At first glance, 
these findings may seem incongruent; however, they can be reasonably 
explained.  Flow-mediated dilation and sublingual nitroglycerin provide the 
vascular smooth muscle cells with the dilator nitric oxide by two very different 
mechanisms.  The first provides NO indirectly but locally via the endothelium.  
The second provides NO directly but systemically.  Our results show that a defect 
in the signal transduction cascades in the smooth muscle is unlikely, as there is 
no systemic change in endothelium-independent NO dilation. 
 
In animal studies, arterial function is usually tested with local intra-arterial 
injections of vasoactive substances or ex-vivo preparations.  Unfortunately, our 
institutional constraints do not allow intra-arterial injections in bed rest subjects.  
Thus, we measured arterial function only from the standpoint of changes in the 
dilatory function of the arteries.  Rat data suggests arterial smooth muscle in the 
lower body would be less able to constrict following head-down tilt (29).  We are 
currently assessing arterial constrictor function in a hypovolemia model which 
has produced changes in left ventricular (LV) mass similar to spaceflight. 
 
Cardiac Function 
This is the most complete echocardiographic assessment of resting cardiac 
structure and function during long duration bed rest of which we are aware.  We 
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found several measures that indicated a decrement in cardiac structure and in 
both systolic and diastolic function. 
 
Left ventricular mass did not change during this study.  Conversely, LV mass has 
been reported to be decreased after spaceflight by both MRI (21) and ultrasound 
techniques (24).  We have previously shown, through mathematical modeling, 
that the post-spaceflight decrease in LV mass is most likely due to interstitial 
dehydration of the myocardium secondary to spaceflight-induced hypovolemia 
(24).  Unfortunately, LV mass has never been measured during spaceflight so it 
is not known if the same effect would occur in the absence of gravity.  In the 
current study, LV mass was measured during head-down tilt, but not measured 
after the subjects resumed ambulatory activity.  This may explain the absence of 
change in LV mass.  A suggestion for future bed rest campaigns is to add a 
measurement early during post-bed rest reconditioning. 
 
Despite the lack of change in LV mass, there were several changes in cardiac 
function.  It is not clear which, if any of these, occurred in response to the 
decrease in preload caused by the hypovolemia.  However, the degree of change 
suggests true changes in function.  In Table II we show that some, but clearly not 
all measures of cardiac performance are changed following bed rest.  There is no 
consensus as to which measures best represent clinically relevant dysfunction in 
bed rested subjects; however, some interesting trends can be gleaned from 
these data.   Isovolumic relaxation time increased significantly during bed rest, 
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indicating decreased diastolic function.  This is similar to results obtained 
following spaceflight (24).  Myocardial performance index, a global measure of 
function which accounts for both systolic and diastolic parameters, showed a 
decrease in performance, suggesting an overall decrease in cardiac function.  It 
is not unusual that echocardiographic measurements of cardiac function seem to 
contradict each other (4).  Each measurement corresponds to parts of the heart 
which are subject to different degrees of influence by aortic, atrial and ventricular 
pressures and volumes. The heterogeneous nature of these results does not 
invalidate their usefulness, rather they illustrate that the effects of bed rest on 
cardiac function are complex and multifactorial.  We have previously reported 
changes in cardiac function following long duration spaceflight that also show a 
heterogeneous pattern (15); however, that study lacked some of the more 
mechanistic measurements that we now present.  From the data in this study, it 
appears as though bed rest and long duration spaceflight both alter cardiac 
function.  It is not clear if these changes are the result of decreases in fluid 
volume and preload, or if they represent a true change in cardiac muscle 
function.   Future spaceflight studies should include more detailed 
echocardiograms to allow for a more direct comparison. 
 
One primary concern is that most measures of cardiac function are somewhat 
preload dependent.  It is well known that preload changes during bed rest, similar 
to spaceflight, due to the pronounced fluid redistribution-induced decrease in 
plasma volume.  This could explain the increase in MPI seen at BR7 and BR21 
 20  
(Table II).  However, it does not explain why MPI further increases on BR31 and 
BR49 because plasma volume has stabilized.  It could be that plasma volume 
accounts for the initial response and another mechanism drives the changes 
seen following 35 days of bed rest.  The second mechanism could include 
cardiac deconditioning due to the decreased aerobic activity required during bed 
rest.  This could lead to a decrease in contractility or possibly a remodeling of the 
myocardium (as supported by decreases in LV diameters, but not LV mass).  
While we were unable to perform statistical analysis on the time points beyond 
BR49, there are obvious trends that suggest that the cardiac changes persist to 
90 days.  Further examination of later time points will provide more insight into 
the ramifications of long term bed rest, and potentially longer term spaceflight, on 
the cardiovascular system. 
 
Limitations 
A major limitation of this study is the subject number at the varying time points.  
This is largely due to the forced evacuation of subjects for Hurricane Rita.  
Therefore, these subjects only completed 44-53 days of the designed 90 day bed 
rest protocol, and only a relatively small number of subjects completed 90 days 
of bed rest.  We have chosen to limit our statistical analysis in this report to the 
first 60 days of bed rest (although we show all data in the figures) in order to 
utilize the data points shared by the most subjects.. 
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Table I.  Vital Statistics and Baseline Memodynamics. 
 pre-Bed rest BR 7 BR 21 BR 35 BR 49 BR 60 BR 75 BR 90 BR+3 
  
1.7 ± 0.1 
        
Height, m 
  
72.6 ± 16.6 
 
72.0 ± 17.0 
 
72.9 ± 14.3 
  
71.4 ± 16.0 
     
Weight, kg 69.8 ± 16.1 65.8 ± 14.2 71.4 ± 24.2 62.9 ± 16.8 65.8 ± 15.2 
  
25.4 ± 4.2 
 
24.6 ± 4.4 
  
25.4 ± 3.7 
 
24.7 ± 4.3 
     
Body Mass 
Index, kg/m2
24.5 ± 4.1 23.6 ± 4.2 26.5 ± 5.9 23.4 ± 4.6 23.7 ± 4.5 
  
118.8 ± 13.2 
 
116.1 ± 8.1 
 
118.7 ± 16.2 
 
115.9 ± 10.9 
     
Systolic 
Pressure, mmHg 
118.2 ± 13.4 116.7 ± 13.9 105.2 ± 8.2 112.7 ± 15.3 109.8 ± 12.0 
  
67.8 ± 8.4 
 
68.3 ± 7.2 
 
69.4 ± 8.8 
 
70.9 ± 6.7 
     
Diastolic 
Pressure, mmHg 
70.5 ± 6.9 69.1 ± 8.3 69.3 ± 7.1 73.5 ± 12.8 68.2 ± 8.8 
  
65.3 ± 8.9 
 
63.0 ± 10.3 
 
65.5 ± 7.7 
 
65.7 ± 11.0 
     
Heart Rate, 71.5 ± 9.5 69.7 ± 10.2 69.5 ± 13.1 67.8 ± 11.9 69.3 ± 13.6 
 
 
beats/min 
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Table II.  Echocardiography Results for Systolic Function, Morphology and Diastolic Function During Pre-Bed Rest, Days 
BR7, BR21, BR31 and BR49 of Bed Rest.  Statistical Analyses are Included in Separate Columns. 
 
 Pre bed 
rest 
Day 7 P 
value 
Day 
21 
P 
value 
Day 
31 
P 
value 
Day 
49 
P 
value 
LV diastolic diameter (cm) 4.94 4.83 NS 4.68 0.015 4.79 NS 4.75 NS 
LV systolic diameter (cm) 3.00 2.78 0.035 2.84 NS 2.91 NS 2.72 0.005 
Ejection fraction 69 73 NS 70 NS 70 NS 74 0.05 
LV mass (g) 118.7 118.7 NS 119.2 NS 114.7 NS 109.9 NS 
Stroke volume 80.3 80.0 NS 71.6 NS 75.4 NS 77.6 NS 
Isovolumic relaxation time (msec) 72.9 85.0 0.025 83.9 0.041 95.9 <0.001 89.2 0.002 
Isovolumic contraction time (msec) 49.1 53.3 NS 47.5 NS 53.0 NS 48.8 NS 
Ejection time(msec) 299 287 NS 281 0.028 282 0.041 275 0.002 
Myocardial performance index 0.41 0.49 0.033 0.47 0.082 0.53 <0.001 0.51 0.004 
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CAPTIONS FOR FIGURES 
Figure 1.  Plasma volume changes during bed rest.  Plasma volume index (PVI) 
is the plasma volume corrected by body surface area.  Significant differences 
from pre-bed rest were seen at all timepoints.  * indicates  P ≤ 0.05 within group 
for bed rest day. 
Figure 2.  Reactive hyperemic responses during bed rest.  These graphs show 
the difference between pre- and post-occlusion (delta) for each timepoint.  There 
were no statistical differences in the brachial artery (left panel) or in the anterior 
tibial artery (right panel). 
Figure 3.  Direct arterial dilation with nitroglycerin.  These graphs show the 
difference between pre- and post-occlusion (delta) for each timepoint.  There 
were no statistical differences in the brachial artery (left panel) or in the anterior 
tibial artery (right panel).  There was a difference found between the brachial and 
anterior tibial artery.  § indicates P ≤ 0.05 between arteries. 
Figure 4.  Intimal medial thickness.  The intimal medial thickness (cm) decreased 
during bed rest in the anterior tibial artery only (right panel).  * indicates  P ≤ 0.05 
within group for bed rest day compared to pre-bed rest.   
Figure 5.  Survival analysis of tilt test standing times.  The solid line represents 
the probability of standing at each time point of the tilt test before bed rest.  The 
dashed line represents the probability of standing following 44-60 days of bed 
rest.  There is a trend for the survival to be lower at day 44-60 than during pre-
bed  rest (P = 0.1). 
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